Beste apotheek van Nederland

Green B G, Martin S. Clinical assessment of sildenafil in the
treatment of neurogenic male sexual dysfunction: After the
hype. NeuroRehabilitation 2000;15(2):101-105.
Greenstein A, Mabjeesh N J, Sofer M et al. Does sildenafil
combined with testosterone gel improve erectile dysfunction in
hypogonadal men in whom testosterone supplement therapy
alone failed?[see comment]. Br J Urol 2005;173(2):530-532.
Gresser U, Gleiter C H. Erectile dysfunction: comparison of
efficacy and side effects of the PDE-5 inhibitors sildenafil,
vardenafil and tadalafil--review of the literature. [Review] [92
refs]. Eur J Med Res 2002;7(10):435-446.
Gross A J, Sauerwein D H, Kutzenberger J et al. Penile
prostheses in paraplegic men. Br J Urol 1996;78(2):262-264.
Grossman E B, Swan S K, Muirhead G J et al. The
pharmacokinetics and hemodynamics of sildenafil citrate in
male hemodialysis patients. Kidney Int 2004;66(1):367-374.
Grover J K, Vats V, Ajeeta. Sildenafil (Viagra(TM)). Medico-
Legal Update 1998;3(1-2):67-78.
Guay A T, Perez J B, Jacobson J et al. Efficacy and safety of
sildenafil citrate for treatment of erectile dysfunction in a
population with associated organic risk factors.[erratum appears
in J Androl 2002 Jan-Feb;23(1):113]. J Androl 2001;22(5):793­
797.
Guay A T, Perez J B, Velasquez E et al. Clinical experience
with intraurethral alprostadil (MUSE) in the treatment of men
with erectile dysfunction. A retrospective study. Medicated
urethral system for erection. Eur Urol 2000;38(6):671-676.
Guay A T, Spark R F, Jacobson J et al. Yohimbine treatment of
organic erectile dysfunction in a dose-escalation trial. Int J
Impot Res 2002;14(1):25-31.
Gupta N, Sawlani K K, Tripathi A K. Appropriate use of
sildenafil citrate in male erectile dysfunction.[see comment].
[Review] [52 refs]. J Assoc Physicians India 2001;49889-896.
Gupta Sanjay, Masand Prakash, Ashton Adam K et al.
Phenelzine-induced sexual dysfunction treated with sildenafil. J
Sex Marital Ther 1999;25(2):131-135.
Gutierrez P, Hernandez P, Mas M. Combining programmed
intracavernous PGE1 injections and sildenafil on demand to
salvage sildenafil nonresponders.. Int J Impot Res
2005;17(4):354-358.
Hammadeh M Y, Madaan S, Hines J et al. 5-year outcome of a
prospective randomized trial to compare transurethral
electrovaporization of the prostate and standard transurethral
resection. Urology 2003;61(6):1166-1171.
Harding L M, Adeniyi A, Everson R et al. Comparison of a
needle-free high-pressure injection system with needle-tipped
injection of intracavernosal alprostadil for erectile dysfunction.
Int J Impot Res 2002;14(6):498-501.
Harrold L R, Gurwitz J H, Field T S et al. The
diffusion of a novel therapy into clinical practice: the
case of sildenafil.[see comment]. Arch Intern Med
2000;160(22):3401-3405.
Harwood P J, Grotz M, Eardley I et al. Erectile
dysfunction after fracture of the pelvis. Journal of
Bone & Joint Surgery - British Volume
2005;87(3):281-290.
Hatzichristou D G. Sildenafil citrate: lessons learned
from 3 years of clinical experience. [Review] [60
refs]. Int J Impot Res 2002;14Suppl-52.
Hatzichristou D G. Current treatment and future
perspectives for erectile dysfunction. [Review] [85
refs]. Int J Impot Res 1998;10Suppl-13.
Hatzichristou D G, Apostolidis A, Tzortzis V et al.
Sildenafil versus intracavernous injection therapy:
efficacy and preference in patients on intracavernous
injection for more than 1 year. Br J Urol
2000;164(4):1197-1200.
Hatzichristou D, Vardi Y, Papp G et al. Effect of
tadalafil on sexual timing behavior patterns in men
with erectile dysfunction: integrated analysis of
randomized, placebo controlled trials. Br J Urol
2005;174(4 Pt 1):1356-1359.
Hatzimouratidis K, Hatzichristou D.
Phosphodiesterase Type 5 Inhibitors: The Day After.
Eur Urol 2007;51(1):75-89.
Hatzimouratidis K, Hatzichristou D G. A comparative
review of the options for treatment of erectile
dysfunction: Which treatment for which patient?.
Drugs 2005;65(12):1621-1650.
Hauck E W, Altinkilic B M, Schroeder-Printzen I et
al. Prostaglandin E1 long-term self-injection
programme for treatment of erectile dysfunction--a
follow-up of at least 5 years. Andrologia
1999;31(Suppl):Suppl-103.
He X Q, Hong B F, Wang X X et al. Evaluation of
efficacy and safety of oral sildenafil citrate therapy for
men with erectile dysfunction. Pharmaceutical Journal
of Chinese Peoples Liberation Army 2002;18(4):205­
208.
Heaton J P. Key issues from the clinical trials of
apomorphine SL. World J Urol 2001;19(1):25-31.
Heaton J P W, Wagner Porst, Eid Wyllie.
Apomorphine: An update of clinical trial results. Int J
Impot Res 2000;12(SUPPL. 4):S67-S73.
Heaton J P, Lording D, Liu S N et al. Intracavernosal
alprostadil is effective for the treatment of erectile
dysfunction in diabetic men. Int J Impot Res
2001;13(6):317-321.
D-169